Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 6, Issue 5 , Pages 386-393 , September 2010

Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells

  • Margaret A. Calciano

      Affiliations

    • ExonHit Therapeutics Inc, Gaithersburg, MD, USA
    • ,
  • Weiyin Zhou

      Affiliations

    • ExonHit Therapeutics Inc, Gaithersburg, MD, USA
    • ,
  • Peter J. Snyder

      Affiliations

    • Lifespan Affiliated Hospitals & Alpert Medical School of Brown University, Providence, RI, USA
    • ,
  • Richard Einstein

      Affiliations

    • ExonHit Therapeutics Inc, Gaithersburg, MD, USA
    • Corresponding Author InformationCorresponding author. Tel.: 240-683-7073; Fax: 240-683-7060.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: The majority of authors are employees of ExonHit Therapeutics, a drug discovery and diagnostic development company. The manuscript utilizes a major technology used for internal and extramural programs for the company. A conflict of interest exists due to the financial interest that the authors have in ExonHit Therapeutics, Inc.

PII: S1552-5260(10)00003-8

doi: 10.1016/j.jalz.2009.12.004

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 6, Issue 5 , Pages 386-393 , September 2010

Article Tools

* Image Usage & Resolution